Chemistry Analyzer and Reagents Keesler AFB
Defense Health Agency · DEFENSE HEALTH AGENCY
Materiality: 0.01% of $ABT revenue (Low) SEC
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation HT940826CE006 in this department, oldest first.
- Mar 10, 2026 · this noticeAward NoticeABBOTT LABORATORIES INC. · $4.5M
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Note the winner and the end of the period of performance for the recompete.
- Follow the agency to see the next notice for this work.
Who won similar work
14 award notices on SAM.gov in the last 24 months. Matched by: Same agency (Defense Health Agency), same product/service code (PSC) 6550.
Single-winner award sizes (14): middle half $272K to $1.6M, median $468K; range $111K to $4.7M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| SYSMEX AMERICA, INC | 2 | $2.8M | Oct 1, 2026 |
| WERFEN USA LLC | 2 | $580K | Aug 19, 2026 |
| BIOFIRE DEFENSE LLC | 1 | $4.7M | Apr 8, 2026 |
| MAPP BIOPHARMACEUTICAL, INC. | 1 | $2.0M | Jun 4, 2025 |
| SAN DIEGO BLOOD BANK San Diego CA 92102 USA | 1 | $1.9M | Jun 22, 2025 |
| QUIDELORTHO SALES COMPANY · $QDEL · $3.0B | 1 | $837K | May 27, 2026 |
| LIFESTREAM BLOOD BANK San Bernardino CA 92408 USA | 1 | $650K | Feb 24, 2025 |
| SL MEDITECH CO. Seongnam-si GYEONGGI-DO 13103 KOR | 1 | $604K | Jun 11, 2026 |
| ARKRAY MARKETING, INC. | 1 | $332K | Nov 14, 2025 |
| ILLUMINA, INC. | 1 | $273K | May 30, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $QDEL reported $3.0B revenue in FY2025. The median single-winner award in these 14 past awards, $468K, is under 0.1% of that. 10-K
One award's total value against one year of revenue; many awards are paid over several years.
- Oct 1, 2026SYSMEX AMERICA, INC$2.7MFY26 Lab Consolidation for Coagulation CPRR EffortNo listed company matched (Materiality N/A)
- Aug 19, 2026WERFEN USA LLC$308KImmunohematology Reagents NMCSDNo listed company matched (Materiality N/A)
- Jun 11, 2026SL MEDITECH CO. Seongnam-si GYEONGGI-DO 13103 KOR$604KHematology and Coagulation AnalyzersNo listed company matched (Materiality N/A)
- May 30, 2026ILLUMINA, INC.$273KIllumina Urinary Pathogen Identification (ID)/Antimicrobial Resistance (AMR) Enrichment Kit (UPIP), (1) Respiratory Pathogen ID/AMR Enrichment Kit Set A,Materiality: <0.01% of $ILMN revenue (Low) SEC
- May 27, 2026QUIDELORTHO SALES COMPANY$837KQuidel Ortho Reagents, Consumables and MaintenanceMateriality: 0.03% of $QDEL revenue (Low) SEC
- Apr 8, 2026BIOFIRE DEFENSE LLC$4.7MBIOFIRE MOLECULAR ANALYZER AT NHCPNo listed company matched (Materiality N/A)
- Jan 5, 2026WERFEN USA LLC$271KCoagulation Analyzers and Reagents Keesler AFBNo listed company matched (Materiality N/A)
- Dec 9, 2025SYSMEX AMERICA, INC$111KSole Source - Hematology Analyzer, JBPHHNo listed company matched (Materiality N/A)
- Nov 14, 2025ARKRAY MARKETING, INC.$332KArkray Urine AnalyzersNo listed company matched (Materiality N/A)
- Jun 22, 2025SAN DIEGO BLOOD BANK San Diego CA 92102 USA$1.9MNaval Medical Center San Diego Blood Products BPANo listed company matched (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 1 of these past winners lobbied Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff since 2024 (9 filings)
- 0 of their lobbyists list a past Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 32 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 1 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.